Breaking News, Collaborations & Alliances

Fujifilm Cellular Dynamics, Lonza Enter Cell Therapy Pact

Agree to expand availability and use of induced pluripotent stem cell technology.

By: Contract Pharma

Contract Pharma Staff

Fujifilm Cellular Dynamics, a global developer and manufacturer of human induced pluripotent stem cells (iPSC) technologies, and Lonza Walkersville, Inc., a leading global GMP iPSC manufacturer, have entered into a partnership. The agreement enables drug developers to leverage both companies’ expertise and technologies for the generation of iPSCs through licensing agreements.   Under the agreement, Fujifilm Cellular Dynamics grants Lonza a non-exclusive right to use their patents related...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters